Cellulac, an innovative Irish company chaired by serial entrepreneur Gerry Brandon, is working on plans to invest €50m in an industrial biochemical plant near Dundalk, according to a report in yesterday’s Sunday Independent.
The company is understood to be in talks with Enterprise Ireland about creating 60 new direct jobs in the region.
Earlier this month, Cellulac agreed terms with Pursuit Dynamics (PDX), a Cambridge technology business, to buy its marine drive subsidiary for £1m (€1.15m) as part of its expansion plans.
In May, Cellulac signed a €3m joint-venture agreement with two partners to develop biodegradable human implants and bring them to market.
It intends for its proposed new business in Dundalk, however, to be making lactic acid, which is used in everything from preserving food to making plastic bags. The market for the chemical is valued at €1bn worldwide and growing.
When contacted by the Sunday Independent, Mr Brandon said: “We’re not in a position to comment yet, but we are certainly looking at a number of operations, one of which is in Ireland, but we cannot confirm anything at this point.”
Mr Brandon previously founded Alltracel, a wound-care company that he listed on London’s AIM before the business was sold for €32m in 2008. Cellulac is understood to be looking to raise funds to invest in its Dundalk plant from the London stock markets.
Source: Cellulac plans €50m biochemcial plant in northeast (Sunday Independent)